ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

AP vs TMO // NET PROFIT MARGIN

Ampco-Pittsburgh Corporation (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: AP 0 — TMO 10
▲ NET PROFIT MARGIN LEADER: TMO
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AP VS. TMO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC AP TMO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 9.30% -44.30 TMO /roic <GO>
EV/EBITDA & P/E Valuation — 30.4x — TIE /valuation <GO>
Free Cash Flow Yield -4.62% 2.40% -7.02 TMO /fcf-yield <GO>
Operating Margin -13.10% 17.40% -30.50 TMO /operating-margins <GO>
Net Profit Margin ACTIVE -15.90% 15.10% -31.00 TMO /net-margins <GO>
Revenue Growth (YoY) 3.30% 3.90% -0.60 TMO /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.24% -0.24 TMO /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.58 4.50 -3.92 TMO /balance-sheet <GO>
Piotroski F-Score Quality 3/9 8/9 -5.00 TMO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 40.0 62.9 -22.90 TMO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.94 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 36.3x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $174.4M $262.22B -$262.04B TMO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR AP REV TMO REV AP GROSS % TMO GROSS % AP FCF TMO FCF
FY 2025 $416.3M $44.56B — — -$8.1M $6.29B
FY 2024 $402.8M $42.88B — — $5.8M $7.27B
FY 2023 $415.3M $42.86B — — -$3.7M $6.48B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AP // BETA —
TMO // BETA 0.94